Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

by Griguolo, Gaia, Dieci, Maria Vittoria, Paré, Laia, Miglietta, Federica, Generali, Daniele Giulio, Frassoldati, Antonio, Cavanna, Luigi, Bisagni, Giancarlo, Piacentini, Federico, Tagliafico, Enrico, Cagossi, Katia, Ficarra, Guido, Prat, Aleix, Conte, Pierfranco, Guarneri, Valentina
Published in NPJ Breast Cancer (2021)

GD2 expression in breast cancer

by Orsi, Giulia, Barbolini, Monica, Ficarra, Guido, Tazzioli, Giovanni, Manni, Paola, Petrachi, Tiziana, Mastrolia, Ilenia, Orvieto, Enrico, Spano, Carlotta, Prapa, Malvina, Kaleci, Shaniko, D’Amico, Roberto, Guarneri, Valentina, Dieci, Maria Vittoria, Cascinu, Stefano, Conte, Pierfranco, Piacentini, Federico, Dominici, Massimo
Published in Oncotarget (2017)

Immune characterization of breast cancer metastases: prognostic implications

by Dieci, Maria Vittoria, Tsvetkova, Vassilena, Orvieto, Enrico, Piacentini, Federico, Ficarra, Guido, Griguolo, Gaia, Miglietta, Federica, Giarratano, Tommaso, Omarini, Claudia, Bonaguro, Serena, Cappellesso, Rocco, Aliberti, Camillo, Vernaci, Grazia, Giorgi, Carlo Alberto, Faggioni, Giovanni, Tasca, Giulia, Conte, Pierfranco, Guarneri, Valentina
Published in Breast Cancer Res (2018)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

by Dieci, Maria Vittoria, Bisagni, Giancarlo, Brandes, Alba A., Frassoldati, Antonio, Cavanna, Luigi, Giotta, Francesco, Aieta, Michele, Gebbia, Vittorio, Musolino, Antonino, Garrone, Ornella, Donadio, Michela, Rimanti, Anita, Beano, Alessandra, Zamagni, Claudio, Soto Parra, Hector, Piacentini, Federico, Danese, Saverio, Ferro, Antonella, Cagossi, Katia, Sarti, Samanta, Gambaro, Anna Rita, Romito, Sante, Bazan, Viviana, Amaducci, Laura, Moretti, Gabriella, Foschini, Maria Pia, Balduzzi, Sara, Vicini, Roberto, D’Amico, Roberto, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco
Published in BMC Med (2019)

Development of a multi-parameter prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

by Prat, Aleix, Guarneri, Valentina, Paré, Laia, Griguolo, Gaia, Pascual, Tomás, Dieci, Maria Vittoria, Chic, Núria, González-Farré, Blanca, Frassoldati, Antonio, Sanfeliu, Esther, Cejalvo, Juan Miguel, Muñoz, Montserrat, Bisagni, Giancarlo, Brasó-Maristany, Fara, Urso, Loredana, Vidal, Maria, Brandes, Alba Ariela, Adamo, Barbara, Musolino, Antonino, Miglietta, Federica, Conte, Benedetta, Oliveira, Mafalda, Saura, Cristina, Pernas, Sònia, Alarcón, Jesús, Llombart-Cussac, Antonio, Cortés, Javier, Manso, Luis, López, Rafael, Ciruelos, Eva, Schettini, Francesco, Villagrasa, Patricia, Carey, Lisa A., Perou, Charles M., Piacentini, Federico, D’Amico, Roberto, Tagliafico, Enrico, Parker, Joel. S., Conte, Pierfranco
Published in Lancet Oncol (2020)